¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Disturbance of cerebral status of newborn, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® cerebral aneurysm ÇÑ±Û ³úµ¿¸Æ·ù, ³úµ¿¸ÆÀÚ·ç
¼³¸í   
  ³úÀÇ µ¿¸Æ¿¡ »ý±ä µ¿¸ÆÀÚ·ç. ÀÓ»óÀûÀ¸·Î Áß¿ä½ÃµÇ´Â ÀÌÀ¯´Â À̰ÍÀÌ Àß ÅÍÁ® ³úÃâÇ÷ÀÇ Áß¿äÇÑ ¿øÀÎÀÌ µÇ±â ¶§¹®ÀÌ´Ù. ´ëºÎºÐÀÇ µ¿¸ÆÀÚ·ç°¡ ÃâÇ÷À» ÀÏÀ¸Å°Áö¸¸ ÃâÇ÷À» ÀÏÀ¸Å°Áö ¾Ê´Â °æ¿ì¿¡´Â ÁÖÀ§ÀÇ ³ú Á¶Á÷ÀÇ ¾Ð¹Ú¿¡ ÀÇÇØ¼­ µÎÅëÀ̳ª ¹ßÀÛ µîÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Ù.
  
  
¿µ¹® cerebral palsy ÇÑ±Û ³ú¼º¸¶ºñ
¼³¸í   
  Ãâ»ýÀü, Ãâ»ý½Ã È¤Àº Ãâ»ýÈÄÀÇ ³úÀÇ ¼±Ãµ±âÇü, ¼Õ»ó È¤Àº ÁßÃ߽Űæ°èÀÇ º´¿¡ ÀÇÇØ¼­ ¿µ±¸ÀûÀ̸ç, ºñÁøÇ༺ÀΠ¿îµ¿½Å°æ ¹× Á¤½ÅÀå¾Ö¸¦ ÀÏÀ¸Å°´Â °æ¿ì¸¦ ¶æÇÑ´Ù. ¿øÀÎÀº ¿©·¯ °¡Áö°¡ ÀÖÀ» ¼ö ÀÖÀ¸³ª Á¶»êÀ¸·Î ÀÎÇÑ ³úÀÇ »ê¼Ò°ø±ÞÀÇ ºÎÁ·, ¶Ç´Â ³­»êÀ¸·Î ÀÎÇѠȣÈíÀå¾Ö µîÀÌ ÈçÇÑ ¿øÀÎÀÌ´Ù. Áõ»óÀº ´ë°³ ºñÁøÇ༺ÀÇ ³ú º´º¯À¸·Î ÀÎÇÑ ¿îµ¿Àå¾Ö°¡ ´ëÇ¥ÀûÀΠÁõ»óÀ̸砱׿ܿ¡ Ã»·Â, ½Ã·ÂÀÇ Àå¾Ö, Áö´ÉºÎÀü, ¾ð¾îÀå¾Ö, °æ·Ã ¹× Á¤½ÅÀå¾Ö µîÀÌ µ¿¹ÝµÉ ¼ö ÀÖ´Ù.
¿µ¹® cerebral contusion ÇÑ±Û ³úÁ»ó
¼³¸í   
  ¿ÜºÎ¿¡¼­ ±â¿øÇϴ ¹°¸®Àû Ãæ°Ý¿¡ ÀÇÇÑ ³úÀÇ ¹°¸®Àû ¼Õ»ó.
¿µ¹® cerebral concussion ÇÑ±Û ³úÁøÅÁ
¼³¸í   
  ¿ÜºÎ¿¡¼­ ±â¿øÇϴ ¹°¸®Àû Ãæ°ÝÀ¸·Î ÀÎÇØ ³úÀÇ ¹°¸®Àû ¼Õ»ó¾øÀÌ ÀϾ´Â ³úÀÇ ±â´É Àå¾Ö. ÀϽÃÀûÀ¸·Î ¹«ÀǽÄ, ¹Ý»ç¼Ò½Ç, µîÀÌ ³ªÅ¸³ªÁö¸¸ °á±¹Àº ¾Æ¹« ÈÄÀ¯Áõ¾øÀÌ Á¤»óÀ¸·Î µ¹¾Æ¿Â´Ù.
  
  
¿µ¹® cerebral cortex ÇÑ±Û ´ë³ú°ÑÁú
¼³¸í   
  ´ë³úÀǠǥ¸éºÎÀ§¸¦ ´ë³ú°ÑÁúÀ̶ó°íµµ ÇÑ´Ù. ´ë°³ ¾èÀºÈ¸»öÁú(superficial gray matter)¿Í µ¿ÀǾî·Î ¾²ÀδÙ. È¸»öÁúÀ̶õ ´ë³úÀǠǥ¸é¿¡ ½Å°æ¼¼Æ÷°¡ ¸ð¿©Àִ °÷À¸·Î È¸»öÀ» ¶ì´Â ºÎºÐÀ» ¸»ÇÑ´Ù. À̿ʹ ´ëÁ¶ÀûÀ¸·Î ¹é»öÁúÀ̶õ ½Å°æ¼¼Æ÷°¡ ³»´Â ½Å°æ¼¶À¯°¡ ºÐÆ÷Çϴ °÷À̸破ë³ú¿¡¼­ È¸»öÁúÀÇ ¾ÈÂÊ¿¡ Á¸ÀçÇÑ´Ù. Âü°í·Î ¸»Çϸé Ã´¼ö¿¡¼­´Â ´ë³ú¿Í ¹Ý´ë·Î È¸»öÁú ¾ÈÂÊ¿¡ Á¸ÀçÇÏ°í ¹é»öÁúÀÌ ¹Û¿¡ Á¸ÀçÇÑ´Ù. Áï Ã´¼ö¿¡¼­´Â ½Å°æ¼¼Æ÷°¡ Ã´¼öÀÇ ¾ÈÂÊ¿¡ Á¸ÀçÇÏ°í ¹Ù±ùÂÊ¿¡ ±× ½Å°æ¼¼Æ÷°¡ ³»´Â ½Å°æ¼¶À¯°¡ Á¸ÀçÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • status lymphaticus
    ¸²ÇÁüÁú
  • status marmoratus
    ´ë¸®¼®Áõ
  • status praesens
    °üÂû½Ã¼Ò°ß, ÇöÁõ(úÞñø)
  • status spongiosus
    °¹¼Ø»óÅÂ, ÇØ¸é»óÅÂ
  • status thymicolymphaticus
    °¡½¿»ù¸²ÇÁüÁú, Èä¼±¸²ÇÁüÁú
  • status thymicus
    °¡½¿»ùüÁú, È伱üÁú
  • association disturbance
    ¿¬»óÀå¾Ö
  • autonomic disturbance
    ÀÚÀ²½Å°æÀå¾Ö
  • dissociated sensory disturbance
    ÇØ¸®°¨°¢Àå¾Ö
  • disturbance
    Àå¾Ö, ±³¶õ
  • disturbance of attention
    ÁÖÀÇ·ÂÀå¾Ö
  • extrapyramidal motor disturbance
    ÇǶó¹Ìµå¹Ù±ù±æ¿îµ¿Àå¾Ö, Ãßü¿Ü·Î¿îµ¿Àå¾Ö
  • ejaculatory disturbance
    »çÁ¤Àå¾Ö
  • electrolyte disturbance
    ÀüÇØÁúÀå¾Ö
  • emotional disturbance
    °¨Á¤Àå¾Ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cerebral infarction
    ³ú°æ»öÁõ
  • internal cerebral vein
    ¼Ó´ë³úÁ¤¸Æ
  • disturbance of attention
    ÁÖÀÇ·ÂÀå¾Ö
  • disturbance
    Àå¾Ö, ±³¶õ
  • atrioventricular conduction disturbance
    ¹æ½ÇÀüµµÀå¾Ö
  • autonomic disturbance
    ÀÚÀ²½Å°æÀå¾Ö
  • intellectual disturbance
    Áö´ÉÀå¾Ö
  • orientation disturbance
    Áö³²·ÂÀå¾Ö, ¹æÇâ°¨Àå¾Ö
  • reflex disturbance
    ¹Ý»çÀå¾Ö
  • sensory disturbance
    °¨°¢Àå¾Ö
  • speech disturbance
    ¾ð¾îÀå¾Ö
  • visual disturbance
    ½Ã·ÂÀå¾Ö, ½Ã°¢Àå¾Ö
  • respiratory disturbance syndrome
    È£ÈíÀå¾ÖÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • status asthmaticus
    õ½ÄÁö¼Ó»óÅÂ
  • status choreaticus
    ¹«µµº´Áö¼Ó»óÅÂ
  • status degenerativus
    º¯Áú»óÅÂ
  • status dysraphicus
    ºÀÇÕÀå¾Ö»óÅÂ
  • status epilepticus
    °æ·ÃÁßøÁõ
  • status hemicranicus
    ÆíµÎÅë»óÅÂ
  • status lymphaticus
    ¸²ÇÁüÁú
  • status marmoratus
    ´ë¸®¼®»óÅÂ
  • status praeperniciosus
    ¾Ç¼ººóÇ÷ÀẹüÁú
  • status praesens
    °üÂû½Ã¼Ò°ß
  • status praesens localis
    ±¹¼Ò¼Ò°ß
  • status spongiosus
    °¹¼Ø»óÅÂ
  • status thymicolymphaticus
    °¡½¿»ù¸²ÇÁüÁú
  • status thymicus
    (¢¡status lymphaticus) ¸²ÇÁüÁú
  • status varicosus
    Á¤¸Æ·ùüÁú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hemolytic disease of newborn
    ½Å»ý¾Æ ¿ëÇ÷¼º Áúȯ
  • hemolytic disease of newborn
    ½Å»ý¾Æ¿ëÇ÷¼º Áúȯ.
  • hemorrhagic disease of newborn
    ½Å»ý¾ÆÃâÇ÷(¼º) Áúȯ.
  • idiopathic respiratory distress of newborn infant =IRDNI
    ½Å»ý¾ÆÆ¯¹ß¼º È£Èí°ï¶õÁõ.
  • CVR=£¾cerebral vascular resistance
    ³úÇ÷°ü(Òàúìη)ÀúÇ×(î½ù÷).
  • CVR=£¾cerebral vascular resistance
    ³úÇ÷°üÀúÇ×.
  • anterior cerebral artery
    ¾Õ´ë³úµ¿¸Æ
  • anterior cerebral veins
    ¾Õ´ë³úÁ¤¸Æ
  • artery, occipital branches of posterior cerebral
    ÈÄ´ë³úµ¿¸ÆÀÇ ÈĵÎÁö{ÇØ}
  • great cerebral vein
    Å«´ë³úÁ¤¸Æ
  • hereditary cerebral hemorrhages with amyloidosis(hchwa)
    À¯Àü¼º ³úÃâÇ÷, ¾Æ¹Ð·ÎÀ̵åÁõ¼º
  • infantile cerebral paralysis
    ¿µ¾Æ(¼º) ³ú¼º¸¶ºñ(?ä®àõÒààõØ«Ýö).
  • inferior cerebral veins
    ¾Æ·¡´ë³úÁ¤¸Æ
  • posterior cerebral a.
    µÚ´ë³úµ¿¸Æ
  • posterior cerebral artery
    µÚ´ë³úµ¿¸Æ, ÈÄ´ë³úµ¿¸Æ(ý­ÓÞÒàÔÑØæ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • newborn anoxia ³ª a. neonatorum
    ½Å»ý¾Æ ¹«<Àú>»ê¼Ò(Áõ)(ãæßæä®Ùí<î¼>ß«áÈñø).
  • newborn baby
    ½Å»ý¾Æ.
  • newborn infant
    ½Å»ý¾Æ.
  • newborn melena ³ª m. neonatorum
    ½Å»ý¾ÆÇ÷º¯, ½Å»ý¾ÆÇÏÇ÷.
  • newborn resuscitation
    ½Å»ý¾Æ¼Ò»ý(¹ý)(~áÌßæÛö).
  • resuscitation of newborn
    ½Å»ý¾Æ¼Ò»ý¹ý(ãæßæä®áÌßæÛö).
  • subcutaneous fat necrosis of newborn
    ½Å»ý¾ÆÇÇÇÏÁö¹æ±«»ç.
  • subcutaneous fat necrosis of newborn
    ½Å»ý¾ÆÇÇÇÏÁö¹æ±«»ç(ãæßæä®ù«ù»ò·Û¸ÎÕÞÝ)
  • transient hyperammonemia of newborn
  • transient tachypnea of newborn
  • transient tyrosinemia of newborn
  • transitory fever of newborn
    ½Å»ý¾Æ(ãæßæä®)Àϰú¼º¿­.
  • transitory fever of newborn
    ½Å»ý¾Æ(ãæßæä®)Àϰú¼º¿­
  • hepatic status
    °£±â´É»óÇØ
  • hepatic status assessment
    °£±â´ÉÆò°¡
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Inferior cerebral veins
    ¾Æ·¡´ë³úÁ¤¸Æ
    [¿¾ ¿ë¾î] ÇÏ´ë³úÁ¤¸Æ
  • Anterior cerebral artery
    ¾Õ´ë³úµ¿¸Æ
    [¿¾ ¿ë¾î] Àü´ë³úµ¿¸Æ
  • Anterior cerebral veins
    ¾Õ´ë³úÁ¤¸Æ
    [¿¾ ¿ë¾î] Àü´ë³úÁ¤¸Æ
  • Superficial cerebral vein
    ¾èÀº´ë³úÁ¤¸Æ
    [¿¾ ¿ë¾î] õ´ë³úÁ¤¸Æ
  • Superficial middle cerebral vein
    ¾èÀºÁß°£´ë³úÁ¤¸Æ
    [¿¾ ¿ë¾î] õÁß´ë³úÁ¤¸Æ
  • Superior cerebral veins
    À§´ë³úÁ¤¸Æ
    [¿¾ ¿ë¾î] »ó´ë³úÁ¤¸Æ
  • Mesencephalic aqueduct [Cerebral aqueduct]
    Áß°£³ú¼öµµ°ü
    [¿¾ ¿ë¾î] Áß³ú¼öµµ
  • Middle cerebral artery
    Áß°£´ë³úµ¿¸Æ
    [¿¾ ¿ë¾î] Áß°£´ë³úµ¿¸Æ
  • Middle cerebral artery
    Áß°£´ë³úµ¿¸Æ
    [¿¾ ¿ë¾î] Áß´ë³úµ¿¸Æ
  • Great cerebral vein
    Å«´ë³úÁ¤¸Æ
    [¿¾ ¿ë¾î] ´ë´ë³úÁ¤¸Æ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cerebral embolism
    ³ú»öÀüÁõ
  • cerebral palsy
    ³ú¼º¸¶ºñ
  • cerebral paragonimiasis
    ³úÆóÈíÃæÁõ, ³úÆÄ¶ó°í´Ï¹«½ºÁõ
  • cerebral peduncle
    ´ë³ú´Ù¸®, ´ë³ú°¢
  • cerebral vascular accident
    ³úÇ÷°ü»ç°í
  • cerebral vascular disease
    ³úÇ÷°üÁúȯ
  • middle cerebral artery
    Áß´ëÁ˵¿¸Æ
  • posterior cerebral artery
    µÚ´ë³úµ¿¸Æ, ÈÄ´ë³úµ¿¸Æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CC calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card...
CM California mastitis [test]; calmodulin; capreomycin; carboxymethyl; cardiac murmur; cardiac muscle; ...
CPC central posterior curve; cerebellar Purkinje cell; cerebral palsy clinic; cerebral performance categ...
CT calcitonin; calf testis; cardiac tamponade; cardiothoracic [ratio]; carotid tracing; carpal tunnel; ...
TCI total cerebral ischemia; transient cerebral ischemia; transcobalamin I
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
N.I.C.U. Newborn Intensive Care Unit
NBS Newborn bovine serum
PPHN Persistent Pulmonary Hypertension of the Newborn
UNHS Universal newborn hearing screening
NB newborn
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • conductive hearing disturbance
    ÀüÀ½¼º ³­Ã»
  • disturbance
    Àå¾Ö
    Á¤»óÀ̶ó°í »ý°¢µÇ´Â °ÍÀ¸·ÎºÎÅÍÀÇ ÀÌÅ» ¶Ç´Â ºÐÁö.
  • disturbance of consciousness
    ÀÇ½Ä Àå¾Ö
  • disturbance of speech
    ¾ð¾î Àå¾Ö
  • electrolyte disturbance
    ÀüÇØÁú Àå¾Ö
  • epithelial disturbance
    »óÇÇ Àå¾Ö
  • extrapyramidal motor disturbance
    Ãßü¿Ü ¿îµ¿Àå¾Ö
  • functional temporomandibular joint disturbance
    ±â´ÉÀû ÃøµÎÇϾǰüÀý Àå¾Ö
  • hearing disturbance
    û·Â Àå¾Ö
    À½À» Á¦´ë·Î ´À³¢Áö ¸øÇÏ´Â »óÅÂ.
  • hemodynamic disturbance
    Ç÷Çà ¿ªÇÐÀû Àå¾Ö
  • hereditary disturbance
    À¯Àü¼º Àå¾Ö
    ¼±ÃµÀûÀ¸·Î ¾î¹öÀ̷κÎÅÍ ÀÚ¼Õ¿¡°Ô ¹°·ÁÁ® ³»¸®´Â Áúº´.
  • labyrinthine disturbance
    ¹Ì·Î Àå¾Ö
  • language disturbance
    ¾ð¾î Àå¾Ö
    µ¿ÀǾî=language disorder.
  • motility disturbance
    ¿îµ¿ Àå¾Ö
  • motor disturbance
    ¿îµ¿ Àå¾Ö
    ¸öÀÇ ¼öÀÇÀû ¿îµ¿, ¿¹¸¦ µé¸é »çÁö, ¸öÅë, ¸ñ, ¾ó±¼, ¾È±¸, Çô µîÀ» ¿òÁ÷ÀÌ´Â ¿îµ¿ÀÌ ÀÚÀÇ·Î Àß ¾È µÇ´Â »óÅÂ. Àå¾Ö¸¦ ÀÏÀ¸Å°´Â ÇØºÎÇÐÀû º´º¯¿¡ µû¶ó Ãßü·Î°èÀÇ ¿îµ¿ Àå¾Ö, ¼Ò³ú°èÀÇ ¿îµ¿ Àå¾Ö, Ãßü¿Ü·Î°èÀÇ ¿îµ¿ Àå¾Ö, ¸»ÃʽŰæ°èÀÇ ¿îµ¿ Àå¾Ö·Î ³ª´­ ¼ö ÀÖ´Ù.¡¼Ãßü·Î°èÀÇ ¿îµ¿ Àå¾Ö¡½ Ãßü·Î´Â ´ë³ú ÇÇÁú¿îµ¿¾ß ÁÖÀ§ÀÇ ±¤¹üÀ§ÇÑ ÇÇÁú ³»¿¡ ÀÖ´Â ¸¹Àº ½Å°æ ¼¼Æ÷µé·ÎºÎÅÍ ½Å°æ ¼¶À¯°¡ ³ª¿Í ¸ð¿©¼­ ³ú°£, ¿¬¼ö¸¦ °ÅÃÄ Ã´¼öÀÇ È¸¹éÁú¿¡ ÀÖ´Â ¿îµ¿ ½Å°æ ¼¼Æ÷¿Í ¿¬Á¢µÉ ¶§±îÁöÀÇ ½Å°æ ¼¶À¯ÀÇ ´Ù¹ßÀ̸ç, ÀÌ °æ·Î¿¡ º´º¯ÀÌ ÀÖÀ» ¶§ ¼öÀÇ ¿îµ¿ Àå¾Ö°¡ ³ªÅ¸³ª´Âµ¥, ƯÈ÷ »çÁöÀÇ ¸»´ÜºÎ¿¡¼­ ½ÉÇÏ´Ù. Áï, ¼¼¹ÐÇϰí Á¤±³ÇÑ ¼Õ°¡¶ôÀÇ ¿òÁ÷ÀÓ µîÀÌ Àß ¾È µÇ°í ½Ã°£ÀÌ °¨¿¡ µû¶ó Àå¾Ö ±ÙÀ°Àº °­Á÷ÇØÁø´Ù.¡¼¼Ò³ú°èÀÇ ¿îµ¿ Àå¾Ö¡½ Ãßü·Î´Â ¿îµ¿ ±â´ÉÀÇ Á¶Á¤ ¹× ÅëÇÕÀÇ ¿ªÇÒ°ú ±Ù ±äÀåÀ» Á¶ÀýÇÏ°í ¸öÀÇ ÆòÇüÀ» À¯ÁöÇÏ´Â µ¥ °ü¿©ÇÑ´Ù. À̰÷¿¡ º´º¯ÀÌ ÀÖÀ¸¸é Á¤±³ÇÑ ¼öÀǿ¿¡ Àå¾Ö°¡ ¿À°í, ±Ù ±äÀå ÀúÇÏ, ±âµµ ÁøÀü, ºÒ¸í·á ¾ð¾î, ¿îµ¿½ÇÁ¶Áõ µîÀÌ ³ªÅ¸³ª¸ç, ÆòÇü ±â´É Àå¾Ö·Î ¶È¹Ù·Î ¼­Áö ¸øÇϰí ÀÚ²Ù ¾²·¯Áö·Á°í ÇÏ¸ç ¼ú ÃëÇÑ »ç¶÷ó·³ °È´Â´Ù.¡¼Ãßü¿Ü·Î°èÀÇ ¿îµ¿ Àå¾Ö¡½ Ãßü¿Ü·Î´Â ¼±»óü, ´ãⱸ·Î ±¸¼ºµÈ ´ë³ú ±âÀú ÇÙ°ú ´ë³ú ÇÇÁú, ½Ã»ó, Áß³ú, ½Ã»ó ÇÏÇÙ, ÈæÁúÀÌ ¹«¼öÇÑ ½Å°æ¼¶À¯·Î ¼­·Î ¿¬°áµÇ¾î ÀÖ¾î, ¼öÀǿÀ» ¼öÇàÇÏ´Â µ¥ ÇÊ¿äÇÑ ÀÚ¼¼ À¯Áö¿Í ¼öÀǿÀ» °è¼Ó °ß½ÇÇÏ°Ô ÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù. ¼±»óü¿¡ º´º¯ÀÌ ÀÖÀ¸¸é ¿©·¯ ÇüÅÂÀÇ ºñÁ¤»ó ºÒ¼öÀǿÀÌ ³ªÅ¸³ª¸ç ±Ù ±äÀåÀÇ Àå¾Öµµ ¿Â´Ù. ºñÁ¤»ó ºÒ¼öÀǿÀ¸·Î´Â ¼Õ, ¸Ó¸®, ÀÔ¼ú µî¿¡ Á¤Áö½Ã ÁøÀü, ¾ÆÅ×Åä½Ã½º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
newborn neonatal, neonate
newborn jaundice <paediatrics> A normal condition of elevated bilirubin in the bloodstream of a newborn.
This occurs secondary to immaturity of liver cells (cannot effectively metabolise bilirubin) and the increased destruction of red blood cells (further releasing bilirubin into the bloodstream) that is normally seen in the newborn.
The jaundice usually appears between the 2nd and 5th days of life and usually clears by 2 weeks. Other factors which can potentiate jaundice in the newborn include: sepsis, biliary atresia, Rhesus incompatibility, galactosaemia, cephalohaematoma, polycythaemia, G-6-P-D deficiency and congenital rubella, syphilis, toxoplasmosis or cytomegalovirus infection.
(10 Jan 1998)
newborn screening Tests of newborns to detect those at increased risk for disorders such as pku (phenylketonuria) and hypothyroidism.
(12 Dec 1998)
subcutaneous fat necrosis of newborn Indurated plaques and nodules appearing usually a few days or a few weeks after birth and usually resolving within a few months, characterised microscopically by birefringent needle-shaped crystals within necrotic fat cells; the condition remains localised, unlike sclerema neonatorum.
(05 Mar 2000)
disease, haemolytic, of the newborn Abnormal breakup of red blood cells in the foetus or newborn.
(12 Dec 1998)
infant, newborn An infant during the first month after birth.
(12 Dec 1998)
infant, newborn, diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both hereditary diseases and metabolism, inborn errors are available as general concepts.
(12 Dec 1998)
jaundice of the newborn Icterus which can be accentuated by many factors including excessive haemolysis, sepsis, neonatal hepatitis or congenital atresia of the biliary system.
Synonym: physiologic icterus, jaundice of the newborn, neonatal jaundice, physiologic jaundice.
(05 Mar 2000)
leukocytosis of the newborn An apparently "physiologic" leukocytosis usually observed in newborn infants, in whom the white blood cell counts are usually greater than 10,000 per cu mm, and sometimes range to 45,000 per cu mm, resulting chiefly from increased numbers of neutrophils (especially single and bilobed forms). On the third or fourth day of life, the count generally decreases rapidly, and then fluctuates for several days; beginning about the fourth week of life, a relative lymphocytosis is observed, and this normally continues for a few years.
(05 Mar 2000)
marital status A demographic parameter indicating a person's status with respect to marriage, divorce, widowhood, singleness, etc.
(12 Dec 1998)
mental status schedule Standardised clinical interview used to assess current psychopathology by scaling patient responses to the questions.
(12 Dec 1998)
wetland indicator status <ecology> The exclusiveness with which a plant species occurs in wetland, the different indicator categories (i.e., facultative species, and obligate wetland species) are defined elsewhere in this glossary.
(09 Oct 1997)
health status The level of health of the individual, group, or population as subjectively assessed by the individual or by more objective measures.
(12 Dec 1998)
health status index Set of measurements designed to detect short-term fluctuations in health of members of a population; the measurements usually include physical function, emotional well-being, activities of daily living, feelings, etc.
(05 Mar 2000)
health status indicators The measurement of the health status for a given population using a variety of indices, including morbidity, mortality, and available health resources.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á